Clinical Trials at Cambridge Medical Center
As of August 2026, 18 paid clinical trials are recruiting at Cambridge Medical Center, located at 121 ADAMS ST S, CAMBRIDGE, MN 55008-1620, phone (763) 442-4111 in Cambridge, Minnesota. Active studies at this site cover conditions such as Ovarian Carcinoma, Plasma Cell Myeloma and Acral Lentiginous Melanoma. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
18 clinical trials at Cambridge Medical Center
·Clear filters·Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial
Ramucirumab and Paclitaxel or FOLFIRI in Advanced Small Bowel Cancers
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
Study of Targeted Therapy vs. Chemotherapy in Patients With Thyroid Cancer
Testing Osimertinib as a Treatment for Lung Cancers With an EGFR Exon 20 Change
Evaluating the Impact of Social and Genetic Factors on Outcomes in Adolescent and Young Adult Cancer Survivors
Comparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM) When a Stem Cell Transplant is Not a Medically Suitable Treatment
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Immune Checkpoint Inhibitor Toxicity Risk Prediction in Solid Tumors
S1703 Serum Tumor Marker Directed Disease Monitoring in Patients With Hormone Receptor Positive Her2 Negative Metastatic Breast Cancer
Prospective Non-Interventional Study Comparing Osimertinib +/- Chemotherapy for EGFR-Mutated NSCLC Patients
Shorter Chemo-Immunotherapy Without Anthracycline Drugs for Early-Stage Triple Negative Breast Cancer
Testing the Use of Chemotherapy After Surgery for High-Risk Pancreatic Neuroendocrine Tumors
Testing Whether the Addition of Carboplatin Chemotherapy to Cabazitaxel Chemotherapy Will Improve Outcomes Compared to Cabazitaxel Alone in People With Castrate-Resistant Prostate Cancer That Has Spread Beyond the Prostate to Other Parts of the Body
A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases
Comparing the Outcome of Immunotherapy-Based Drug Combination Therapy With or Without Surgery to Remove the Kidney in Metastatic Kidney Cancer, the PROBE Trial
Common conditions studied in Cambridge
- Ovarian Carcinoma (2 active studies)
- Plasma Cell Myeloma (2 active studies)
- Acral Lentiginous Melanoma (1 active study)
- Advanced Lung Non-Small Cell Carcinoma (1 active study)
- Anatomic Stage I Breast Cancer AJCC v8 (1 active study)
- Anatomic Stage II Breast Cancer AJCC v8 (1 active study)
Leading research sponsors in Cambridge
- SWOG Cancer Research Network
- ECOG-ACRIN Cancer Research Group
- NRG Oncology
- National Cancer Institute (NCI)
- PrECOG, LLC.
Frequently asked questions
How many paid clinical trials are currently recruiting in Cambridge?
There are approximately 18 recruiting clinical trials in Cambridge, Minnesota listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Cambridge pay participants?
Most recruiting trials in Cambridge compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Cambridge?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Cambridge?
The most common conditions under active study in Cambridge include Ovarian Carcinoma (2), Plasma Cell Myeloma (2), Acral Lentiginous Melanoma (1), Advanced Lung Non-Small Cell Carcinoma (1), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Cambridge?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Cambridge on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Cambridge?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Cambridge?
Recruiting research sites in Cambridge include Cambridge Medical Center, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Cambridge right now?
The largest active categories in Cambridge are Cancer & tumors (16). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.
What is the address of Cambridge Medical Center?
Cambridge Medical Center is located at 121 ADAMS ST S, CAMBRIDGE, MN 55008-1620. Use the Google Maps link in the intro above to get directions.
How do I contact Cambridge Medical Center?
You can reach Cambridge Medical Center by phone at (763) 442-4111. For questions about a specific trial, use the study coordinator contact listed on the individual study record — click any trial title above to open it.